Meta-analysis of medium and long-term efficacy of loading statins after coronary artery bypass grafting

Annals of Thoracic Surgery

Volumn 101, Issue 3, 2016, Pages 990-995

  Bin, Cheng ^a   Junsheng, Mu ^a   Jianqun, Zhang ^a   Ping, Bo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG EFFICACY; HEART INFARCTION; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; LOADING DRUG DOSE; META ANALYSIS; NEWCASTLE OTTAWA SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; RESTENOSIS; SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); CORONARY ARTERY DISEASE; FOLLOW UP; TIME FACTOR; TREATMENT OUTCOME;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84958600769     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2015.08.075     Document Type: Article

References (16)

1. C.P. Cannon, E. Braunwald, C.H. McCabe, et al. The Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
2. C.W. White, F.L. Gobel, L. Campeau, et al. Post Coronary Artery Bypass Graft Trial Investigators Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial Circulation 104 2001 2660 2665
3. M. Hata, T. Takayama, A. Sezai, I. Yoshitake, A. Hirayama, and K. Minami Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease Ann Thorac Surg 88 2009 1440 1444
4. S.J. Shah, D.D. Waters, P. Barter, and et al. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery J Am Coll Cardiol 51 2008 1938 1943
5. G.L. Knatterud, Y. Rosenberg, L. Campeau, and et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators Circulation 102 2000 157 165
6. E.S. Brilakis, J.A. de Lemos, C.P. Cannon, and et al. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials) Am J Cardiol 102 2008 552 558
7. M. Domanski, X. Tian, J. Fleg, and et al. Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial Am J Cardiol 102 2008 1023 1027
8. L. Campeau, G.L. Knatterud, M. Domanski, et al. Post Coronary Artery Bypass Graft Trial Investigators The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts N Engl J Med 336 1997 153 162
9. P. Alaupovic, J.D. Fesmire, D. Hunnighake, and et al. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial Atherosclerosis 146 1999 369 379
10. S.C. Smith Jr., J. Allen, S.N. Blair, and et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2006 2363 2372
11. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
12. S.M. Grundy, J.I. Cleeman, C.N. Merz, and et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
13. D.D. Waters, and R.R. Azar Postscripts from the Post-Coronary Artery Bypass Graft trial: the sustained benefit of more aggressive cholesterol lowering and the enigma of low-dose anticoagulation Circulation 102 2000 144 146
14. C. Antoniades, A.S. Antonopoulos, J.K. Bendall, and K.M. Channon Targeting redox signaling in the vascular wall: from basic science to clinical practice Curr Pharm Des 15 2009 329 342
15. C.P. Cannon, E. Braunwald, C.H. McCabe, et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy - Thrombolysis in Myocardial Infarction 22 Investigators Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
16. J.A. de Lemos, M.A. Blazing, S.D. Wiviott, et al. Investigators Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316